DRIO DarioHealth Corp.

$7.00 -1.55%

Healthcare · Surgical & Medical Instruments & Apparatus

DarioHealth Corp. (DRIO) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $51 million. Shares last traded at $7.00, 60.1% below their 52-week high. Over the past year the stock is up 900.0%. Net profit margin is -186.6%, below the peer median of -7.6%. Revenue declined 17.3% year over year.

Market Cap

$51M

Shares Out

7.3M

EPS (TTM)

$13.50

P/E Ratio

0.52

P/S Ratio

2.29

P/B Ratio

0.82

Dividend / Share

—

Dividend Yield

—

52-Week High

$17.54

52-Week Low

$0.39

Volume

111

Avg Vol (3m)

273

Performance

-2.78%

-15.46%

-23.08%

-42.69%

YTD

-33.87%

+900.00%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

40.11

SMA (50)

$7.60

SMA (200)

$10.25

Price vs SMA50

-7.87%

Price vs SMA200

-31.70%

ATR (14)

$0.61

Financials

Revenue

$22M

Net Income

$-42M

Gross Margin

56.6%

Operating Margin

-163.9%

Net Margin

-186.6%

Return on Equity

-66.9%

Return on Assets

-40.4%

Current Ratio

3.07

Debt / Equity

0.50

Revenue Growth (YoY)

-17.3%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$1.25	2026-05-13
FY 2025	$10.12	2026-03-19
Q3 2025	$9.05	2025-11-13
Q2 2025	$0.33	2025-08-12
Q1 2026	$2.87	2026-05-13
FY 2025	$12.27	2026-03-19

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

DRIO vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

2.29 / 2.52 med

-9% discount

Net margin vs peers

-186.6% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.